Donald Bryden

Welcome to Aviva Investors. The global asset manager that chooses integration. The future is full of questions. Only by working closely with our clients can we find the answers. That’s why we integrate our whole business around our clients – their goals, their values and the experience they have when they work with us. That’s why we start by listening closely and understanding their investment aspirations and concerns – from low prospective investment returns, to highly correlated asset prices; from the prospect of rising global interest rates, to the challenges and opportunities of market volatility. Through our vast collective industry experience, we’ve been through every market cycle, making us better prepared for the next one. Inspired by our deep client insight, we build solutions that aim to defy uncertainty, answering the questions that keep our clients awake at night. From large institutional investors to individuals saving for retirement, we work together to deliver meaningful outcomes, now and over the long run. That’s why we work hard to join the dots across asset classes to find the best investment ideas; why we break down barriers so our teams can connect seamlessly; and why we manage risk with discipline and rigour. By working in partnership, we bring components together in new ways to ensure our clients get the very best of our collective expertise with every investment. Please remember the value of an investment and any income from it can go down as well as up. Investors may not get back the original amount invested.

SGD Pharma has unique know-how and offers innovative premium quality primary packaging compliant with international pharmacopoeias. From design to manufacturing, our teams will support you in the development and implementation of your project. SGD Pharma’s corporate quality policy is applied in all of its manufacturing facilities and is compliant with pharmaceutical Good Manufacturing Practices (GMPs). Recognizing that the patient is the end user of its products, SGD Pharma implements the strictest quality standards. All of our manufacturing sites are fully dedicated to pharmacy and are according to ISO 15378 standards. Each of our vials is inspected and packed in an ISO 8 (class 100,000) clean room. In the pharmaceutical industry more than anywhere else, security of the supply chain is critical. We protect our clients and their patients by making every effort to ensure a continuous supply of glass. SGD Pharma provides back-up solutions from its different manufacturing sites for all types of glass. Our global footprint and vast distribution network allow us to serve you wherever you are in the world.

Oaktree is a leader among global investment managers specializing in alternative investments, with $223 billion in assets under management as of December 31, 2025. The firm emphasizes an opportunistic, value-oriented, and risk-controlled approach to investments in credit, equity, and real estate. The firm has more than 1,500 employees and offices in 26 cities worldwide. For additional information, please visit Oaktree’s website at http://www.oaktreecapital.com/. Please be aware of fraudulent LinkedIn accounts posing as Oaktree employees, claiming to be recruiting for job opportunities at the firm. If you’ve encountered or become aware of any suspicious activity, please alert oaktreelinkedin@oaktreecapital.com and share any relevant messages and screenshots for reference. We’re working closely with LinkedIn to address this issue as soon as possible. For important disclosures, please visit http://www.oaktreecapital.com/socialmedia and https://www.oaktreecapital.com/fraud-and-phishing.